Loading...
ROCO
3430
Market cap134mUSD
Jul 09, Last price  
128.00TWD
1D
-1.16%
1Q
77.04%
Jan 2017
779.12%
IPO
599.07%
Name

Chitec Technology Co Ltd

Chart & Performance

D1W1MN
ROCO:3430 chart
P/E
40.58
P/S
2.52
EPS
3.15
Div Yield, %
1.95%
Shrs. gr., 5y
2.35%
Rev. gr., 5y
8.09%
Revenues
1.71b
+16.19%
571,763,000649,612,000908,092,000897,569,000832,678,000909,624,000825,954,000744,866,000760,850,000944,306,0001,338,936,0001,321,456,0001,159,671,0001,497,058,0001,597,730,0001,262,475,0001,472,533,0001,710,908,000
Net income
106m
-34.09%
-29,608,00013,489,00040,602,00050,788,00049,267,00057,479,00042,152,00022,111,00016,480,00036,047,000143,581,00075,716,00041,785,000130,769,000196,204,000120,239,000161,370,000106,352,000
CFO
135m
-5.58%
-21,686,00047,998,00062,329,00056,368,00028,089,00049,611,000-7,929,000-27,297,00028,208,00081,522,000273,265,000-9,939,000172,061,000296,936,000262,918,000150,058,000142,828,000134,864,000
Dividend
Jul 09, 20252.5 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Chitec Technology Co., Ltd. is a global enterprise dedicated to the research and development of specialized chemical solutions. These advanced materials serve a broad spectrum of applications across various industries, such as electronics, healthcare, automotive, and construction. Its extensive product range features several proprietary brands, including 'Chiguard' for UV absorbers and light stabilizers, 'Zuran' for flame retardants, 'Revonox/Deox' for antioxidants, and 'Chivacure/R-gen' for photoinitiators. Furthermore, the 'Chitex' brand covers anti-reversion agents, antiozoants, optical brighteners, and auxiliary thermal stabilizers. The company, founded in 1998, is headquartered in Taipei City, Taiwan.
IPO date
Sep 16, 2010
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT